Mounjaro®
Starting from £179.99/mo
Start journey Learn moreVomiting after eating on semaglutide is one of the most commonly reported side effects, particularly in the first few weeks of treatment or after a dose increase. It happens because semaglutide slows the rate at which the stomach empties, so eating too quickly or too much can tip the balance. Most people find it settles as their body adjusts — but knowing what drives it, and what to watch for, makes a real difference. These are prescription-only medicines, and any concerns about how you're tolerating treatment should be discussed with your prescriber rather than managed alone.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide acts on GLP-1 receptors in the gut as well as the brain. One of its core mechanisms is slowing gastric emptying, food moves from the stomach to the small intestine more slowly than usual. That is partly how it reduces appetite and calorie intake. The downside is that the stomach becomes more sensitive to volume and speed. If you want to understand more about vomiting after taking Wegovy, including why it happens and what influences it, that page covers the mechanism in detail alongside practical context.
Dose increases tend to be the flashpoint. The full side-effect profile of Wegovy shows that GI symptoms cluster around the transition from one dose to the next, then gradually ease. If you started on 0.25mg without much trouble and then found 0.5mg or 1.0mg more difficult around mealtimes, that pattern is consistent with what clinical trials reported. The NHS medicines page for semaglutide confirms nausea and vomiting as common effects in this class.
A quick check you can build into your day: before sitting down to eat, gauge your portion against roughly two-thirds of what you would normally have served yourself. It takes under a minute and, for many people on semaglutide, prevents the overfull feeling that precedes vomiting.
Eating behaviour matters more on semaglutide than it did before. Three practical changes tend to make the biggest difference: eating slowly (putting cutlery down between bites is a reliable prompt), keeping portions smaller and more frequent rather than two or three large meals, and reducing high-fat or highly processed foods that sit heaviest in a slowed stomach.
Fatty foods are worth particular attention. Fat is the slowest macronutrient to leave the stomach even in people not taking GLP-1 medicines. Combined with semaglutide's gastric-slowing effect, a high-fat meal is the combination most likely to end badly. Spicy food and alcohol can have a similar effect for some people. Eating in an upright position and staying upright for at least 30 minutes after a meal also reduces reflux-related vomiting.
Hydration is a separate issue. If vomiting is occurring, fluids (taken in small sips rather than large glasses) need to replace what is lost. Plain water and oral rehydration solutions are more useful than fizzy drinks. People who find solid food reliably triggers vomiting sometimes do better starting meals with a small amount of bland food (plain crackers, plain rice, toast) before the stomach is completely empty. Those dealing with nausea and sickness specifically linked to eating on Wegovy often find meal timing around the injection day matters too, some people feel worse in the 24 to 48 hours after their weekly dose.
Most vomiting on semaglutide is unpleasant but self-limiting. There are specific patterns that need prompt medical assessment rather than home management.
Get urgent medical help if vomiting is accompanied by severe, persistent pain in the upper abdomen that spreads to the back. That combination can indicate acute pancreatitis, which the MHRA highlighted in a January 2026 Drug Safety Update as a known but infrequent serious side effect of GLP-1 medicines. Pancreatitis is rare, but the symptom pattern is distinct enough to act on immediately rather than wait and see.
Also seek medical help if: vomiting is so frequent that you cannot keep fluids down for more than a few hours; you are showing signs of dehydration (dark urine, dizziness on standing, dry mouth, no urine output for several hours); vomiting contains blood or material that looks like coffee grounds; or your symptoms are getting significantly worse rather than settling over two to three weeks. These are not situations to manage with eating adjustments alone.
Contact your prescriber or GP rather than stopping treatment without advice, abrupt discontinuation is not always the right answer, and there may be options such as pausing at a lower dose. More detail on vomiting as a semaglutide side effect and on combined GI symptoms on Wegovy is available in related pages. For persistent fatigue alongside GI symptoms, the page on tiredness after eating on Wegovy covers the overlap.
Semaglutide for weight management is only available with a prescription following clinical assessment. At nume, a GPhC-registered Independent Prescriber reads every consultation personally, side-effect history, current medicines, and overall suitability are all part of that review. Check your eligibility with our prescribers to understand whether Wegovy is appropriate for you.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.